The Cell and Gene Therapy stream highlights cutting-edge solutions for scaling, controlling, and democratizing access to advanced therapies. Covering viral and non-viral modalities, the program features advances in stable producer lines, capsid engineering, mRNA-LNP platforms, and process intensification. Key sessions explore AI, robotics, and analytics to streamline workflows and enable real-time decision-making. With focused discussion on in vivo CAR T, Point-of-Care models, and global regulatory strategy, the stream underscores how smart manufacturing is unlocking faster, more affordable, and more equitable delivery of cell and gene therapies to patients worldwide.

Conferences Include: